MedPath
HSA Approval

ARIPIPRAZOLE MEVON TABLETS 15 MG

SIN17181P

ARIPIPRAZOLE MEVON TABLETS 15 MG

ARIPIPRAZOLE MEVON TABLETS 15 MG

February 18, 2025

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N05AX12

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

Pharmathen International S.A

Active Ingredients

Aripiprazole

15 mg

Aripiprazole

Documents

Package Inserts

EDL3.1b 1.4.3 Package Insert_ARIPI_Jan 25_clean.docx

Approved: February 18, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ARIPIPRAZOLE MEVON TABLETS 15 MG - HSA Approval | MedPath